Exchange: NASDAQ·Updated 12:34 PM EDT
JUNS logo

JUNS Jupiter Neurosciences Inc.

$3.43
$0.0016
(0.05%)
Today
Mkt Cap$4.19M
Vol9,184.00

About JUNS

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
40

Bearish Sentiment

How do you feel about JUNS?

Advertisement|Remove ads.